Castration-Sensitive Prostate Carcinoma trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Castration-Sensitive Prostate Carcinoma trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
  NCT06931340 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.